Cargando…
The soy-derived peptide Lunasin inhibits invasive potential of melanoma initiating cells
Lunasin is a 44 amino acid peptide with multiple functional domains including an aspartic acid tail, an RGD domain, and a chromatin-binding helical domain. We recently showed that Lunasin induced a phenotype switch of cancer initiating cells (CIC) out of the stem compartment by inducing melanocyte-a...
Autores principales: | Shidal, Chris, Inaba, Jun-Ichi, Yaddanapudi, Kavitha, Davis, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421948/ https://www.ncbi.nlm.nih.gov/pubmed/28424421 http://dx.doi.org/10.18632/oncotarget.16066 |
Ejemplares similares
-
Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin
por: Devapatla, Bharat, et al.
Publicado: (2017) -
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells
por: Shidal, Chris, et al.
Publicado: (2016) -
The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein
por: McConnell, Elizabeth J., et al.
Publicado: (2014) -
Potential Health Benefits Associated with Lunasin Concentration in Dietary Supplements and Lunasin-Enriched Soy Extract
por: Gonzalez de Mejia, Elvira, et al.
Publicado: (2021) -
Scalable Purification and Characterization of the Anticancer Lunasin Peptide from Soybean
por: Seber, Lauren E., et al.
Publicado: (2012)